Role of troponin T in disease

Molecular and Cellular Biochemistry

Volumn 263, Issue 1, 2004, Pages 115-129

  Gomes, Aldrin V ^a   Barnes, Junor A ^b   Harada, Keita ^a   Potter, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Calcium; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Muscle contraction; Nemaline myopathy; Troponin T

Indexed keywords

CONTRACTILE PROTEIN; PROTEIN SUBUNIT; TROPOMYOSIN; TROPONIN T;

AMINO ACID SEQUENCE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC GROUP; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE MUTATION; GENETIC CODE; HEART DEVELOPMENT; HUMAN; LETHALITY; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE FUNCTION; MUTATIONAL ANALYSIS; NEMALINE MYOPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RECESSIVE GENE; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; SYMPTOMATOLOGY; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DNA; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUSCLE CONTRACTION; MUSCULAR DISEASES; MUTATION; MYOPATHIES, NEMALINE; PHENOTYPE; TROPONIN T;

ANIMALIA; MUS MUSCULUS;

EID: 3042791328     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000041853.20588.a0     Document Type: Review

References (101)

1. McKenna WJ, Camm AJ: Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 80: 1489-1492, 1989
2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92: 785-789, 1995
3. Roberts R: Molecular genetics. Therapy or terror? Circulation 89: 499-502, 1994
4. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG: A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell 62: 999-1006, 1990
5. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND: Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13: 63-69, 1996
6. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE: Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 77: 701-712, 1994
7. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE: Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11: 434-437, 1995
8. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg HP, Fiszman M, Kamajda M, Schwartz K: Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 11: 438-440, 1995
9. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T: Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16:379-382, 1997
10. Mogensen J, Klausen IC, Pedersen AK, Egeblad H, Bross P, Kruse TA, Gregersen N, Hansen PS, Baandrup U, Borglum AD: Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 103: R39-R43, 1999
11. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A: Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene. Biochem Biophys Res Commun 262: 411-417, 1999
12. Hoffmann B, Schmidt-Traub H, Perrot A, Osterziel KJ, Gessner R: First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 17: 524, 2001
13. Grunig E, Tasman JA, Kucherer H, Franz W, Kubler W, Katus HA: Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31: 186-194, 1998
14. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED, Seidman JG, Seidman CE: Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343: 1688-1696, 2000
15. Li D, Czernuszewicz GZ, Gonzalez O, Tapscott T, Karibe A, Durand JB, Brugada R, Hill R, Gregoritch JM, Anderson JL, Quinones M, Bachinski LL, Roberts R: Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 104: 2188-2193, 2001
16. Ilkovski B, Cooper ST, Nowak K, Ryan MM, Yang N, Schnell C, Durling HJ, Roddick LG, Wilkinson I, Kornberg AJ, Collins KJ, Wallace G, Gunning P, Hardeman EC, Laing NG, North KN: Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet 68: 1333-1343, 2001
17. Durling HJ, Reilich P, Muller-Hocker J, Mendel B, Pongratz D, Wallgren-Pettersson C, Gunning P, Lochmuller H, Laing NG: De novo missense mutation in a constitutively expressed exon of the slow alpha-tropomyosin gene TPM3 associated with an atypical, sporadic case of nemaline myopathy. Neuromuscul Disord 12:947-951, 2002
18. Donner K, Ollikainen M, Ridanpaa M, Christen HJ, Goebel HH, de Visser M, Pelin K, Wallgren-Pettersson C: Mutations in the beta-tropomyosin (TPM2) gene - A rare cause of nemaline myopathy. Neuromuscul Disord 12: 151-158, 2002
19. Wallgren-Pettersson C, Donner K, Sewry C, Bijlsma E, Lammens M, Bushby K, Giovannucci Uzielli ML, Lapi E, Odent S, Akcoren Z, Topaloglu H, Pelin K: Mutations in the nebulin gene can cause severe congenital nemaline myopathy. Neuromuscul Disord 12: 674-679, 2002
20. Johnston JJ, Kelley RI, Crawford TO, Morton DH, Agarwala R, Koch T, Schaffer AA, Francomano CA, Biesecker LG: A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet 67: 814-821, 2000
21. Sanoudou D, Beggs AH: Clinical and genetic heterogeneity in nemaline myopathy - A disease of skeletal muscle thin filaments. Trends Mol Med 7: 362-368, 2001
22. 2+-troponin-tropomyosin system. J Biochem (Tokyo) 79: 48P-49P, 1976
23. Zot AS, Potter JD: Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biophys Biophys Chem 16: 535-559, 1987
24. White SP, Cohen C, Phillips GN Jr.: Structure of co-crystals of tropomyosin and troponin. Nature 325: 826-828, 1987
25. Stefancsik R, Jha PK, Sarkar S: Identification and mutagenesis of a highly conserved domain in troponin T responsible for troponin I binding: Potential role for coiled coil interaction. Proc Natl Acad Sci USA 95: 957-962, 1998
26. 2+ saturated form. Nature 424: 35-41, 2003
27. 2+ regulation of muscle contraction. J Biol Chem 270: 2557-2562, 1995
28. Fraser ID, Marston SB: In vitro motility analysis of actin-tropomyosin regulation by troponin and calcium. The thin filament is switched as a single cooperative unit. J Biol Chem 270: 7836-7841, 1995
29. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY: Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 31: 106-110, 2002
30. Perry SV: Troponin T: genetics, properties and function. J Muscle Res Cell Motil 19: 575-602, 1998
31. Farza H, Townsend PJ, Carrier L, Barton PJ, Mesnard L, Bahrend E, Forissier JF, Fiszman M, Yacoub MH, Schwartz K: Genomic organisation, alternative splicing and polymorphisms of the human cardiac troponin T gene. J Mol Cell Cardiol 30: 1247-1253, 1998
32. Townsend PJ, Barton PJ, Yacoub MH, Farza H: Molecular cloning of human cardiac troponin T isoforms: Expression in developing and failing heart. J Mol Cell Cardiol 27: 2223-2236, 1995
33. Antin PB, Zhang W, Bales MA, Garriock RJ, Yatskievych TA: Precocious expression of cardiac troponin T in early chick embryos is independent of bone morphogenetic protein signaling. Dev Dyn 225: 376, 2002
34. 2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart. J Biol Chem 277: 35341-35349, 2002
35. Schachat FH, Diamond MS, Brandt PW: Effect of different troponin T-tropomyosin combinations on thin filament activation. J Mol Biol 198: 551-554, 1987
36. Tobacman LS, Lee R: Isolation and functional comparison of bovine cardiac troponin T isoforms. J Biol Chem 262: 4059-4064, 1987
37. Knollmann BC, Potter JD: Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. Trends Cardiovasc Med 11: 206-212, 2001
38. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE: Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058-1064, 1995
39. Anan R, Shono H, Kisanuki A, Arima S, Nakao S, Tanaka H: Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 98: 391-397, 1998
40. Forissier JF, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, Hainque B, Townsend PJ, Yacoub MH, Faure S, Dubourg O, Millaire A, Hagege AA, Desnos M, Komajda M, Schwartz K: Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 94: 3069-3073, 1996
41. Lin T, Ichihara S, Yamada Y, Nagasaka T, Ishihara H, Nakashima N, Yokota M: Phenotypic variation of familial hypertrophic cardiomyopathy caused by the Phe(110)→Ile mutation in cardiac troponin T. Cardiology 93: 155-162, 2000
42. Ho CY, Lever HM, DeSanctis R, Farver CF, Seidman JG, Seidman CE: Homozygous mutation in cardiac troponin T: Implications for hypertrophic cardiomyopathy. Circulation 102: 1950-1955, 2000
43. Nakajima-Taniguchi C, Matsui H, Fujio Y, Nagata S, Kishimoto T, Yamauchi-Takihara K: Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy. J Mol Cell Cardiol 29: 839-843, 1997
44. Varnava A, Baboonian C, Davison F, de Cruz L, Elliott PM, Davies MJ, McKenna WJ: A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 82: 621-624, 1999
45. Szczesna D, Zhang R, Zhao J, Jones M, Guzman G, Potter JD: Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J Biol Chem 275: 624-630, 2000
46. Tobacman LS, Lin D, Butters C, Landis C, Back N, Pavlov D, Homsher E: Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy. J Biol Chem 274: 28363-28370, 1999
47. Nakaura H, Yanaga F, Ohtsuki I, Morimoto S: Effects of missense mutations Phe110Ile and Glu244Asp in human cardiac troponin T on force generation in skinned cardiac muscle fibers. J Biochem (Tokyo) 126: 457-460, 1999
48. Takahashi-Yanaga F, Ohtsuki I, Morimoto S: Effects of troponin T mutations in familial hypertrophic cardiomyopathy on regulatory functions of other troponin subunits. J Biochem (Tokyo) 130: 127-131, 2001
49. Harada K, Takahashi-Yanaga F, Minakami R, Morimoto S, Ohtsuki I: Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T. J Biochem (Tokyo) 127: 263-268, 2000
50. Mukherjea P, Tong L, Seidman JG, Seidman CE, Hitchcock-DeGregori SE: Altered regulatory function of two familial hypertrophic cardiomyopathy troponin T mutants. Biochemistry 38: 13296-13301, 1999
51. Nakaura H, Morimoto S, Yanaga F, Nakata M, Nishi H, Imaizumi T, Ohtsuki I: Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy. Am J Physiol 277: C225-C232, 1999
52. 2+ regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein. Circ Res 86: 1146-1152, 2000
53. Schonberger J, Seidman CE: Many roads lead to a broken heart: The genetics of dilated cardiomyopathy. Am J Hum Genet 69: 249-260, 2001
54. Hanson EL, Jakobs PM, Keegan H, Coates K, Bousman S, Dienel NH, Litt M, Hershberger RE: Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy. J Card Fail 8: 28-32, 2002
55. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H: Sudden death due to troponin T mutations. J Am Coll Cardiol 29: 549-555, 1997
56. Fujino N, Shimizu M, Ino H, Okeie K, Yamaguchi M, Yasuda T, Kokado H, Mabuchi H: Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy. Clin Cardiol 24: 397-402, 2001
57. Fujino N, Shimizu M, Ino H, Yamaguchi M, Yasuda T, Nagata M, Konno T, Mabuchi H: A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am J Cardiol 89: 29-33, 2002
58. Robinson P, Mirza M, Knott A, Abdulrazzak H, Willott R, Marston S, Watkins H, Redwood C: Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 277: 40710-40716, 2002
59. 2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci USA 99: 913-918, 2002
60. Marian AJ, Roberts R: On Koch's postulates, causality and genetics of cardiomyopathies. J Mol Cell Cardiol 34: 971-974, 2002
61. Oberst L, Zhao G, Park JT, Brugada R, Michael LH, Entman ML, Roberts R, Marian AJ: Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J Clin Invest 102: 1498-1505, 1998
62. Lim DS, Oberst L, McCluggage M, Youker K, Lacy J, DeMayo F, Entman ML, Roberts R, Michael LH, Marian AJ: Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 365-374, 2000
63. Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL, Robbins J, Leinwand LA: Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 104: 469-481, 1999
64. Tardiff JC, Factor SM, Tompkins BD, Hewett TE, Palmer BM, Moore RL, Schwartz S, Robbins J, Leinwand LA: A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest 101: 2800-2811, 1998
65. Frey N, Franz WM, Gloeckner K, Degenhardt M, Muller M, Muller O, Merz H, Katus HA: Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias. Cardiovasc Res 47: 254-264, 2000
66. Knollmann BC, Blatt SA, Horton K, de Freitas F, Miller T, Bell M, Housmans PR, Weissman NJ, Morad M, Potter JD: Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy. J Biol Chem 276: 10039-10048, 2001
67. Miller T, Szczesna D, Housmans PR, Zhao J, de Freitas F, Gomes AV, Culbreath L, McCue J, Wang Y, Xu Y, Kerrick WG, Potter JD: Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation. J Biol Chem 276: 3743-3755, 2001
68. Gomes AV, Miller T, Jaquez O, Ampie L, Potter JD: Impaired regulatory properties of a truncated slow skeletal troponin T that causes nemaline myopathy. Biophys J 84: 319A, 2003
69. Yuasa K, Michibata H, Omori K, Yanaka N: A novel interaction of cGMP-dependent protein kinase I with troponin T. J Biol Chem 274: 37429-37434, 1999
70. Jaquet K, Fukunaga K, Miyamoto E, Meyer HE: A site phosphorylated in bovine cardiac troponin T by cardiac CaM kinase II. Biochim Biophys Acta 1248: 193-195, 1995
71. 2+)-stimulated MgATPase activity in reconstituted actomyosin and isolated myofibrils, and decreases actin-myosin interactions. J Mol Cell Cardiol 25: 53-65, 1993
72. 2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol 275: C200-C207, 1998
73. Biesiadecki BJ, Elder BD, Yu ZB, Jin JP: Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals with high instances of dilated cardiomyopathy. J Biol Chem 107, 2002
74. Palm T, Graboski S, Hitchcock-DeGregori SE, Greenfield NJ: Disease-causing mutations in cardiac troponin T: Identification of a critical tropomyosin-binding region. Biophys J 81: 2827-2837, 2001
75. Sarko J, Pollack CV Jr.: Cardiac troponins. J Emerg Med 23: 57-65, 2002
76. Mair J: Cardiac troponin I and troponin T: Are enzymes still relevant as cardiac markers? Clin Chim Acta 257: 99-115, 1997
77. Wu AH, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor G: Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 44: 1198-1208, 1998
78. Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH: Quality specifications for cardiac troponin assays. Clin Chem Lab Med 39: 175-179, 2001
79. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W: Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 67: 1360-1367, 1991
80. Voss EM, Sharkey SW, Gernert AE, Murakami MM, Johnston RB, Hsieh CC, Apple FS: Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Infarct sizing using serum profiles. Arch Pathol Lab Med 119: 799-806, 1995
81. Ricchiuti V, Zhang J, Apple FS: Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling. Clin Chem 43: 990-995, 1997
82. Varnava AM, Elliott PM, Baboonian C, Davison F, Davies MJ, McKenna WJ: Hypertrophic cardiomyopathy: Histopathological features of sudden death in cardiac troponin T disease. Circulation 104:1380-1384, 2001
83. Marian AJ, Roberts R: The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:655-670, 2001
84. D'Cruz LG, Baboonian C, Phillimore HE, Taylor R, Elliott PM, Varnava A, Davison F, McKenna WJ, Carter ND: Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy. J Med Genet 37: E18, 2000
85. Ackerman MJ, VanDriest SL, Ommen SR, Will ML, Nishimura RA, Tajik AJ, Gersh BJ: Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: A comprehensive outpatient perspective. J Am Coll Cardiol 39: 2042-2048, 2002
86. 2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 274: 8806-8812, 1999
87. Morimoto S, Nakaura H, Yanaga F, Ohtsuki I: Functional consequences of a carboxyl terminal missense mutation Arg278Cys in human cardiac troponin T. Biochem Biophys Res Commun 261: 79-82, 1999
88. Lin D, Bobkova A, Homsher E, Tobacman LS: Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest 97: 2842-2848, 1996
89. Harada K, Szczesna D, Hernandez O, Potter JD: Effect of human cardiac troponin T mutations linked to familial hypertrophic cardiomyopathy (FHC) on the force-pCa relationship in skinned human muscle fibers. Biophys J 82: A391, 2002
90. Sweeney HL, Feng HS, Yang Z, Watkins H: Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci USA 95: 14406-14410, 1998
91. Watkins H, Seidman CE, Seidman JG, Feng HS, Sweeney HL: Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest 98: 2456-2461, 1996
92. Rust EM, Albayya FP, Metzger JM: Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J Clin Invest 103: 1459-1467, 1999
93. Koga Y, Toshima H, Kimura A, Harada H, Koyanagi T, Nishi H, Nakata M, Imaizumi T: Clinical manifestations of hypertrophic cardiomyopathy with mutations in the cardiac beta-myosin heavy chain gene or cardiac troponin T gene. J Card Fail 2: S97-S103, 1996
94. Genomics of Cardiovascular Development A, and Remodeling: NHLBI Program for Genomic Applications, Beth Israel Deaconess Medical Center, URL: http://www.cardiogenomics.org, Aug 2003
95. Elliott PM, D'Cruz L, McKenna WJ: Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin T gene [letter]. N Engl J Med 341: 1855-1856, 1999
96. Erdmann FJ, Wischke S, Riedel K, Kallisch H, Fleck ME, Regitz-Zagrosek FV: A new mutation (Arg-278-Pro) in the cardiac troponin T gene (TNNT2) was identified in one patient with typical hypertrophic cardiomyopathy (HCM). Circulation 98: 1273, 1998
97. Watkins H, MacRae C, Thierfelder L, Chou YH, Frenneaux M, McKenna W, Seidman JG, Seidman CE: A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet 3: 333-337, 1993
98. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic Cardiomyopathy. Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107: 2227-2232, 2003
99. Van Driest SL, Ellsworth EG, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 108: 445-451, 2003
100. Garcia-Castro M, Reguero JR, Batalla A, Diaz-Molina B, Gonzalez P, Alvarez V, Cortina A, Cubero GI, Coto E. Hypertrophic cardiomyopathy: Low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients. Clin Chem 49: 1279-1285, 2003
101. Venkatraman G, Harada K, Gomes AV, Kerrick GW, Potter JD. Different functional properties of Troponin T mutants that cause dilated cardiomyopathy. J Biol Chem 278: 41670-41676, 2003.